| Cvs Pharmacy #02163 | |
| 3003 Rte 130 South & Tenby Chase Dr, Delran, New Jersey 08075 | |
| (856) 764-5624 |
| Name | Cvs Pharmacy #02163 |
|---|---|
| Organization Name | New Jersey Cvs Pharmacy Llc |
| Location | 3003 Rte 130 South & Tenby Chase Dr, Delran, New Jersey 08075 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (856) 764-5624 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Mayes College of Healthcare Business and Policy at University of the Sciences is hosting a panel discussion on hepatitis C prevention and treatment, on Thursday, April 28, 2011, from 5 to 7 p.m.
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, is pleased to announce it has signed a worldwide non-exclusive licensing agreement with the National Institutes of Health ('NIH'), a division of the U.S. Department of Health and Human Services, for use of the melanoma antigens TRP-2 and gp100, key components of Scancell's lead ImmunoBody® vaccine for melanoma, SCIB1.
Pharmacy benefit managers (PBMs) have pioneered tools - including incentivizing the use of generic medications, e-prescribing, and mail-service pharmacies - that improve savings, access, and safety for consumers and payers. Since the key to access is affordability, payers and policymakers alike should explore broader use of PBMs' cost-savings tools and reject approaches that make prescription drugs more expensive.
A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that Galderma S.A. (Galderma), a global company dedicated to dermatology has received its first three Pliaglis marketing licenses from E.U. countries.
› Verified 2 days ago
| NPI Number | 1427140904 |
| Organization Name | NEW JERSEY CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY 02163 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3003 Rte 130, South & Tenby Chase Dr, Delran, NJ 08075 |
| Phone Number | 609-764-5624 |
News Archive
Mayes College of Healthcare Business and Policy at University of the Sciences is hosting a panel discussion on hepatitis C prevention and treatment, on Thursday, April 28, 2011, from 5 to 7 p.m.
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, is pleased to announce it has signed a worldwide non-exclusive licensing agreement with the National Institutes of Health ('NIH'), a division of the U.S. Department of Health and Human Services, for use of the melanoma antigens TRP-2 and gp100, key components of Scancell's lead ImmunoBody® vaccine for melanoma, SCIB1.
Pharmacy benefit managers (PBMs) have pioneered tools - including incentivizing the use of generic medications, e-prescribing, and mail-service pharmacies - that improve savings, access, and safety for consumers and payers. Since the key to access is affordability, payers and policymakers alike should explore broader use of PBMs' cost-savings tools and reject approaches that make prescription drugs more expensive.
A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that Galderma S.A. (Galderma), a global company dedicated to dermatology has received its first three Pliaglis marketing licenses from E.U. countries.
› Verified 2 days ago
News Archive
Mayes College of Healthcare Business and Policy at University of the Sciences is hosting a panel discussion on hepatitis C prevention and treatment, on Thursday, April 28, 2011, from 5 to 7 p.m.
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, is pleased to announce it has signed a worldwide non-exclusive licensing agreement with the National Institutes of Health ('NIH'), a division of the U.S. Department of Health and Human Services, for use of the melanoma antigens TRP-2 and gp100, key components of Scancell's lead ImmunoBody® vaccine for melanoma, SCIB1.
Pharmacy benefit managers (PBMs) have pioneered tools - including incentivizing the use of generic medications, e-prescribing, and mail-service pharmacies - that improve savings, access, and safety for consumers and payers. Since the key to access is affordability, payers and policymakers alike should explore broader use of PBMs' cost-savings tools and reject approaches that make prescription drugs more expensive.
A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that Galderma S.A. (Galderma), a global company dedicated to dermatology has received its first three Pliaglis marketing licenses from E.U. countries.
› Verified 2 days ago
Shoprite Pharmacy Of Delran Type: Pharmacy Location: 1310 Fairview Blvd, Delran, New Jersey 08075 Phone: (856) 824-1102 | |
Cvs Pharmacy #02163 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3003 Rte 130 South & Tenby Chase Dr, Delran, New Jersey 08075 Phone: (856) 764-5624 | |
Cvs Pharmacy #17190 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4004 Route 130, Delran, New Jersey 08075 Phone: (856) 544-9051 | |
Rite Aid Pharamcy #00706 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4004 Route 130, Delran, New Jersey 08075 Phone: (856) 461-1250 | |
Walgreens #11333 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7001 Route 130, Delran, New Jersey 08075 Phone: (856) 461-2152 |